In pediatric tumors, the expression of CTLA-4 was detected in glioblastoma, neuroblastoma, and sarcomas, particularly in osteosarcoma, suggesting its potential role as a target for immunotherapy [92,95,102,109]. This evidence concerns the gene CTLA4 and osteosarcoma.